Khus (Vetiveria zizanioides) — Hermetica Encyclopedia
Herbs (Global Traditional) · Ayurveda

Khus (Vetiveria zizanioides) (Vetiveria zizanioides)

Moderate Evidencebotanical

Hermetica Superfood Encyclopedia

The Short Answer

Vetiver (Vetiveria zizanioides) is an aromatic grass containing vetivone and vetiselinenol that modulates GABA neurotransmission and inflammatory pathways. Animal studies suggest potential anxiolytic and anticonvulsant properties through GABAergic enhancement and oxidative stress reduction.

PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerbs (Global Traditional)
GroupAyurveda
Evidence LevelModerate
Primary Keywordvetiver benefits
Synergy Pairings3
Khus close-up macro showing natural texture and detail — rich in antioxidant, anti-inflammatory, sedative
Khus (Vetiveria zizanioides) — botanical close-up

Health Benefits

Origin & History

Khus growing in India — natural habitat
Natural habitat

Khus (Vetiveria zizanioides) is a perennial grass native to India with an extensive root system from which essential oil is extracted via steam distillation. The resulting amber-colored oil is rich in sesquiterpenes and has been traditionally used in tropical regions for over 2,000 years.

In Ayurveda and Siddha medicine systems, khus roots have been used for over 2,000 years for inflammation, pain, infections, fever reduction, anxiety, and metabolic disorders. Traditional preparations include decoctions, pastes, and oils for both topical and oral applications.Traditional Medicine

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on khus. Research is limited to preclinical studies including a rat epilepsy model (PMID: 39576294) showing reduced seizure duration with 200-400 mg/kg vetiver oil, and mouse studies demonstrating anxiolytic and nootropic effects at 100-300 mg/kg ethanolic root extract.

Preparation & Dosage

Khus prepared as liquid extract — pairs with Ashwagandha, Brahmi, Gotu Kola
Traditional preparation

No clinically studied human dosages exist. Animal studies used 100-300 mg/kg oral ethanolic root extract for cognitive effects and 200-400 mg/kg oral vetiver oil for epilepsy models. Human equivalent doses cannot be reliably extrapolated. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

{"macronutrients": {"fiber": "Approximately 3-5% by weight", "protein": "Low, typically less than 1% by weight"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts"}, "minerals": {"Potassium": "Moderate levels, approximately 100-150 mg/100g", "Calcium": "Low levels, approximately 10-20 mg/100g"}}, "bioactive_compounds": {"Vetiverol": "Major component, approximately 50-60% of essential oil", "Khusimol": "Significant component, approximately 10-15% of essential oil", "Zizanoic acid": "Minor component, less than 5% of essential oil"}, "bioavailability_notes": "The bioavailability of vetiver's bioactive compounds can vary based on extraction method and preparation. Essential oils are typically used for therapeutic purposes, and their absorption can be enhanced through topical application or inhalation."}

How It Works

Mechanism of Action

Vetiver's bioactive compounds vetivone and vetiselinenol appear to enhance GABAergic neurotransmission, potentially through positive allosteric modulation of GABA-A receptors. The herb also demonstrates anti-inflammatory activity by inhibiting pro-inflammatory cytokines and reducing lipid peroxidation markers. These dual mechanisms may contribute to its observed neuroprotective and anxiolytic effects in preclinical models.

Clinical Evidence

Current evidence for vetiver is limited to animal and in vitro studies, with no published human clinical trials. Rat studies using 200-400 mg/kg doses showed reduced seizure duration and oxidative stress markers in epilepsy models. Mouse anxiety studies demonstrated anxiolytic activity at 100-300 mg/kg doses in elevated plus maze and open field tests. The preliminary nature of this evidence limits conclusions about human efficacy and optimal dosing.

Safety & Interactions

Safety data for vetiver supplementation in humans is extremely limited due to lack of clinical trials. Traditional use suggests generally good tolerance, but potential side effects, drug interactions, and contraindications remain poorly characterized. Pregnancy and breastfeeding safety is unknown and should be avoided. Individuals taking anticonvulsant medications or anxiolytics should consult healthcare providers before use due to potential additive effects on GABAergic pathways.

Synergy Stack

Hermetica Formulation Heuristic

Frequently Asked Questions

What compounds in vetiver are responsible for its effects?
Vetivone and vetiselinenol are the primary bioactive compounds identified in vetiver root extracts. These sesquiterpene compounds appear to modulate GABA neurotransmission and possess anti-inflammatory properties in laboratory studies.
How much vetiver was used in animal studies?
Animal studies used doses ranging from 100-400 mg/kg body weight, with 200-400 mg/kg showing anticonvulsant effects and 100-300 mg/kg demonstrating anxiolytic activity. These dosages cannot be directly translated to human equivalents without clinical trials.
Can vetiver interact with anxiety medications?
Vetiver may theoretically interact with GABAergic medications like benzodiazepines due to its apparent GABA-enhancing effects in animal studies. However, specific interaction data is lacking, making medical consultation essential before combining with anxiety medications.
Is vetiver safe during pregnancy?
Vetiver safety during pregnancy and breastfeeding is unknown due to absence of human safety studies. Given the lack of safety data and potential GABAergic effects, pregnant and nursing women should avoid vetiver supplementation.
What's the difference between vetiver oil and vetiver extract?
Vetiver essential oil is primarily used for aromatherapy and contains volatile compounds, while vetiver root extracts used in studies contain concentrated levels of vetivone and vetiselinenol. The extracts showing biological activity in research differ significantly from commercial essential oils in composition and potency.
What does current clinical research show about vetiver for epilepsy and seizure management?
Current evidence for vetiver in epilepsy is limited to preliminary animal studies, where doses of 200–400 mg/kg reduced seizure duration in rats. No human clinical trials have been conducted to confirm these effects in people with epilepsy. Vetiver should not be used as a replacement for prescribed anticonvulsant medications without medical guidance.
Who might benefit most from vetiver supplementation based on available research?
Based on preclinical studies, vetiver may be of interest to individuals seeking natural anxiolytic support, as doses of 100–300 mg/kg showed activity in animal anxiety models. Additionally, its in vitro anti-inflammatory properties (reducing TNF-α and IL-1β) suggest potential relevance for those interested in oxidative stress reduction, though human evidence remains absent. Clinical confirmation in human populations is needed before specific populations can be definitively recommended for supplementation.
How does the strength of vetiver evidence compare to other traditional anxiety herbs?
Vetiver's evidence base consists mainly of animal and in vitro studies, making it weaker than some better-studied anxiolytic herbs like ashwagandha or L-theanine, which have human clinical data. Most vetiver research has focused on rodent models at high doses (100–400 mg/kg), which don't directly translate to human supplementation doses. More rigorous human trials are needed to establish vetiver's efficacy and safety relative to other established herbal options.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.